Russia

BMI View: We believe Russia's latest healthcare reform law will act as a further modernising force and, due to late-stage amendments, is broadly positive for the pharmaceutical industry.... 2011-12-12

BMI View: Early-stage discussions to decide on a new method for the Russian authorities to regulate the compensated price of medicines creates new risks for drugmakers operating in... 2011-11-08

BMI View: Russia looks set to receive the green light for WTO membership during a conference in Geneva in mid-December, completing a long and drawn-out accession process that has lasted... 2011-11-02

BMI View: European drugmakers continue to dominate Russia's pharmaceutical market. While there is evidence that US firms have been increasing their involvement and focus in the country,... 2011-10-14

BMI View: Central and Eastern Europe (CEE)'s attractiveness to drugmakers has improved. BMI's Pharmaceuticals and Healthcare Business Environment Ratings (BERs), which assess markets... 2011-10-12

BMI View: While it is likely that the sale of Chinese-made pharmaceuticals in Russia will continue to increase in the coming years, we do not believe these producers offer the Russian... 2011-09-19

BMI View: Despite real and continued operating risks to pharmaceutical companies present in Russia, BMI maintains the view that the size and growth potential of the Russian pharmaceutical... 2011-09-02